Canadian Cancer Society Innovation Grant

Innovation Grants

Please see the eligibility and requirements section prior to creating an application.

Deadline dates

Abstract registration due date: December 15, 2017

Full application due date: March 29, 2018
Results announcement: mid-late July, 2018
Anticipated start date: August 1, 2018

Application guides can be found on the EGrAMS documentation for applicants page. See FAQs.

Abstract registration must be completed in order to submit a full application.


The Canadian Cancer Society (CCS) in partnership with the Canadian Institutes of Health Research-Institute of Cancer Research (CIHR-ICR), will jointly fund the Innovation Grants program. Proposed work should incorporate multi-pronged high risk/high reward approaches and stimulate new partnerships between researchers and experts in the cancer field.

Please see the ‘Partners description’ section below for more information on the CIHR-ICR.

In addition, as a result of a generous donation, there is funding available for a meritorious application focused on uterine cancer. Applications are encouraged in this area.

Program description

Innovation Grants have been created to support innovative, creative problem solving in cancer research. As competition for grant funding increases, peer review panels become more conservative and risk averse, emphasizing feasibility more than innovation. The goal of this CCS Research grant program is to support unconventional concepts, approaches or methodologies to address problems in cancer research. Innovation projects will include elements of creativity, curiosity, investigation, exploration and opportunity. Successful projects may be based on “high risk” ideas, but will have the potential for “high reward” (i.e. to significantly impact our understanding of cancer and generate new approaches to combat the disease by introducing novel ideas into use or practice).

It is hoped that this grant program will accelerate the introduction of innovation into the entire cancer research system and contribute to the scientific idea pipeline. Significant findings from investigators funded by Innovation Grants may be developed further through CCS Research "Innovation to Impact" Grants or operating grants offered by other agencies.

Scientific focus of the program

The purpose of this funding initiative is to support unique, creative research ideas that will impact cancer. Although this grant program is primarily designed to support the biomedical, translational and clinical research communities, applications from all areas and disciplines of cancer research will be considered eligible for funding and will be evaluated based on a common set of criteria. Applicants are required to submit proposals for studies that explicitly address the Society’s mission to eradicate cancer and enhance the quality of life of people living with cancer.

Agency Name: 
Canadian Cancer Society
Contact Name: 
Penny D'Agnone
Grant Amount: 
Grant budgets may be up to $100,000 per year and a maximum of $200,000 per grant. Grant expenditures may be extended over 3 years if justified in the application. Grants will be non-renewable. Funding will be provided to support the direct costs of research, including supplies, salaries, and equipment associated with the proposed work. Equipment requests cannot exceed 25% of the requested budget. Indirect costs are not eligible. It is anticipated that up to 30 grants will be awarded in this competition.
Grant Location: 
External Deadline: 
Friday, December 15, 2017
Grant Type: 
Grant Area: 
Grant Eligibility: